SANES

10.482

-0.61%↓

BBVA

19.26

-0.57%↓

BNP

92.25

-1.09%↓

CABK

11.345

-0.44%↓

INGA

25.035

-0.85%↓

SANES

10.482

-0.61%↓

BBVA

19.26

-0.57%↓

BNP

92.25

-1.09%↓

CABK

11.345

-0.44%↓

INGA

25.035

-0.85%↓

SANES

10.482

-0.61%↓

BBVA

19.26

-0.57%↓

BNP

92.25

-1.09%↓

CABK

11.345

-0.44%↓

INGA

25.035

-0.85%↓

SANES

10.482

-0.61%↓

BBVA

19.26

-0.57%↓

BNP

92.25

-1.09%↓

CABK

11.345

-0.44%↓

INGA

25.035

-0.85%↓

SANES

10.482

-0.61%↓

BBVA

19.26

-0.57%↓

BNP

92.25

-1.09%↓

CABK

11.345

-0.44%↓

INGA

25.035

-0.85%↓

Начало・Списък с акции・AB Science SA

AB Science SA

Затворен

0.86 -2.93

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.86

Максимум

0.915

Ключови измерители
By Trading Economics
Приходи	8.8M 3.6M
Продажби	144K 659K
Марж на печалбата	549.317
Служители	36
EBITDA	1.8M -727K

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-2.4M 66M
Предишно отваряне	3.79
Предишно затваряне	0.86

AB Science SA Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.06.2026 г., 23:49 ч. UTC

Пазарно говорене

Nikkei May Fall Following Tech Stock Declines on Wall Street -- Market Talk

9.06.2026 г., 23:45 ч. UTC

Придобивния, сливания и поглъщания

Correct: Sigma Healthcare: Has Engaged in Preliminary Discussions in Boots Sale Process

9.06.2026 г., 23:44 ч. UTC

Придобивния, сливания и поглъщания

Sigma Healthcare Says No Certainty That Any Transaction Will Eventuate

9.06.2026 г., 23:44 ч. UTC

Придобивния, сливания и поглъщания

Sigma Healthcare: Continuously Reviews Opportunities to Create Value For Shareholders

9.06.2026 г., 23:43 ч. UTC

Придобивния, сливания и поглъщания

Sigma Healthcare: Has Engaged in Preliminary Discussions to Sell Boots

9.06.2026 г., 23:35 ч. UTC

Пазарно говорене

Oil Rises on Escalating Supply Disruption Concerns -- Market Talk

9.06.2026 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Samsung: Element Has Expanded Rapidly Since 2022 Launch of AVITI

9.06.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Samsung: Element to Speed Commercialization of Gene-Sequencing Products

9.06.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Samsung: Additional Investment Makes It Largest Shareholder in Element

9.06.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Samsung Electronics Raises Stake in Element Biosciences With $175 Million Investment

9.06.2026 г., 20:51 ч. UTC

Печалби

Micron, Marvell, Super Micro, Coherent, Smucker, and More Stocks That Explain Today's Market -- Barrons.com

9.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.06.2026 г., 20:09 ч. UTC

Пазарно говорене

Cryptocurrency Traders Look for Bitcoin Bottom -- Market Talk

9.06.2026 г., 19:36 ч. UTC

Пазарно говорене

Cattle Climbs as Crude Oil Falls -- Market Talk

9.06.2026 г., 19:32 ч. UTC

Пазарно говорене

Barclays Oil Price Outlook Contingent on Hormuz Reopening -- Market Talk

9.06.2026 г., 19:25 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Slip in Rangebound Trade -- Market Talk

9.06.2026 г., 19:00 ч. UTC

Пазарно говорене

Oil Settles Lower on Continued Hopes for Middle East Deal -- Market Talk

9.06.2026 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

Warner Bros. Stock Hits a Low. Its Paramount Merger Return Is Getting Buzz. -- Barrons.com

9.06.2026 г., 18:47 ч. UTC

Пазарно говорене

No World Cup Inflation Seen So Far in Mexico -- Market Talk

9.06.2026 г., 18:37 ч. UTC

Пазарно говорене

Canada's Cooling Trade With the U.S. -- Market Talk

9.06.2026 г., 18:27 ч. UTC

Пазарно говорене

Precious Metals Lower as Trump Vows Military Response -- Market Talk

9.06.2026 г., 17:35 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Briefly Rise on Trump's Iran Retaliation Threat -- Market Talk

9.06.2026 г., 17:30 ч. UTC

Пазарно говорене

Trump Post on Apache Helicopter Causes Brief Spike in Oil -- Market Talk

9.06.2026 г., 16:34 ч. UTC

Пазарно говорене

Cryptocurrency Weakness Follows Selling in Equities -- Market Talk

9.06.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.06.2026 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.06.2026 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

9.06.2026 г., 15:28 ч. UTC

Пазарно говорене

Gold Futures Fall Further as Rate Fears Prevail -- Market Talk

9.06.2026 г., 15:25 ч. UTC

Пазарно говорене

Oil Extends Losses, Falling More Than 3.5% -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

AB Science SA Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на AB Science SA през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.